Navigation Links
Medical Personnel Can Save More Lives by Screening for Oral Signs of Disease

icularly hard hit are the city's Black and Hispanic populations, which account for 81 percent of new HIV diagnoses, as reported this past September by the New York City Department of Health and Mental Hygiene.

Dr. Cohen-Brown explains to providers the laws about HIV testing, what occurs in pre-counseling, and the types of tests available. Dentists can’t do HIV testing (New York State has strict requirements about providing counseling with testing), but can refer patients to clinics, hospitals and agencies such as the Brooklyn AIDS Task Force that perform confidential or anonymous testing, especially the Rapid HIV Test, which delivers negative results in 20 minutes.

Just as importantly, she informs her audiences on how to bring up the subject of HIV/AIDS testing -- where to refer patients, how to help them access those places, what needs to be done and what to expect.

And since success in steering patients to HIV testing may hinge on the ability to remain nonjudgmental, she also gives her audiences examples from her former oral pathology practice on how to approach patients in a way that won’t make them panic. “The more comfortable you are, the more comfortable they’ll be," she says. "You have to know which questions will elicit answers. As long as I’m not judgmental, the patient will be comfortable.”

Dr. Cohen-Brown, whose advanced studies in oral and maxillofacial pathology led her from dental practice into teaching, works with the AIDS Institute, the New York State Department of Health and the Department of Corrections, lecturing on mandated cleanliness standards, equipment maintenance, exposure prevention, infection control, post-exposure medication and how the HIV Rapid Testing kit works.

In addition to all her teaching and the workshops she conducts, Dr. Cohen-Brown recently was featured in the Audio Conference on Oral Health and Pregnancy, which went out to community health workers at 80 sites through
'"/>




Page: 1 2 3 4

Related medicine news :

1. Indian Nationals with Foreign Medical Degrees can now practice in India
2. Meditation Works Medically
3. Sleep Disorders Could Indicate Other Medical Problems
4. Being Obese Increases Ones Risk Of A wrong Diagnosis During Medical Imaging
5. Hypnosis Found To Reduce Stress In Children During Medical Procedures
6. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
7. Ayurvedic Therapies Cashing In On Medical Tourism
8. Prevention And Timely Medical Care Can Help With Bug Bites
9. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
10. Grant of $7 million for Orissa Medical College from Japan
11. Indian Hospitals – A Destination For Quality Medical Care
Post Your Comments:
(Date:7/9/2008)..., Barcelona, Spain: New figures on assisted repro... has been an explosion in the use of ICSI (intracy...he 24th annual meeting of the European Society of ...lona heard today (Wednesday). Researchers believe ... too often. , In 2005 the most recent year for ...
(Date:7/8/2008)..., Alexandria, Va.A study conducted in Sweden foun...untry whose wives died from cancer four or five ye...hat their spouse,s cancer was incurable, or they h...life. Eighty-six percent of widowers believed next...ancer is incurable, including 71 percent of the me...
(Date:7/8/2008)... CHICAGO, July 8 /PRNewswire/ -- Last month th...e Improvements for Patient and Providers Act",(H.R...re payments to,physicians and other providers went...ent relationship in great jeopardy., , To view t...ewswire.com/mnr/osteopathic/33934/ , The American...
(Date:7/8/2008)... Heart Failure Study Validates Use of Pharos In...ing Platform to Reduce Healthcare Utilization and ...IELD, Ill., July 8 /PRNewswire/ -- Pharos Innovati...t generation clinical and financial,performance im...platform,announced today the results from the Iow...
Breaking Medicine News(10 mins):Health News:Researcher say that ICSI may be over-used in some countries 2Health News:Researcher say that ICSI may be over-used in some countries 3Health News:Study finds that significant proportion of men told wife's cancer was incurable late or not at all 2Health News:Audio: Medicare Cuts Threaten Access to Health Care for Seniors 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 2Health News:Iowa Medicaid Demonstration Finds Tel-Assurance(R) Remote Monitoring Platform Improved Health Status and Saved $5 Million 3
...esident Bhairon Singh Shekhawat Tuesday launched t... aimed at creating awareness on HIV/AIDS// among t..., conceived by the ministry of youth affairs, will...ontrol Organisation (NACO) in collaboration with o...
... will soon become the first province in Canada to ...have died of heart failure//. The provincial agen...ed that changes in guidelines that allowed accepti...atory death (DCD) could potentially expand the pot...
...lson, one of the worst affected in the catastrophi...ome overnight after over three months in hospital/...to return back to the hospital within a few weeks ...nd toes, which have been going black with dry gang...
...ional Institute for Clinical Excellence (Nice) sai...to combat high blood pressure//. Government medic...prescribed are to be replaced with more effective ...was found that beta-blockers though control blood ...
Other Medicine News:Health News:Vice President Launches AIDS Awareness Campaign for Youth 2Health News:Ontario Addresses Shortage of Transplant Organs 2
(Date:7/8/2008)...tudy of Clevudine versus Viread(R) versus Cle...titis B, PRINCETON, N.J., July 8 /PRNewswire-Firs...on AIDS and Viral Hepatitis (ANRS), with the suppo... Sciences, Inc. (Nasdaq: GILD ),has initiated th...(R),(tenofovir disoproxil fumarate) administered s...
(Date:7/7/2008)...resence Includes ANA598 and ANA773 Acting via ...hanisms Conference Call Today at ...all/ -- Anadys Pharmaceuticals,Inc. (Nasdaq: AND...nvestigation of the Toll-Like Receptor-7 (TLR7) me...Based on preclinical pharmacology testing,and the ...
(Date:7/7/2008).../- Light Sciences Oncology, Inc.,(LSO...atients with benign,prostatic hyperplasia (BPH), o...n Therapy(TM) (Litx(TM)), an innovative light-acti...to conduct a 12-patient, Phase I/II,dose-escalatio... as a,40-patient, Phase IIa study in Australia, ex...
(Date:7/7/2008)...ire-FirstCall/ -- GeoVax Labs, Inc. (OTC,Bulletin ...opharmaceutical,company specializing in the preven...rovided an operational update on the company,s pro...clinical trial testing and,plans to proceed into t...e,successful human trials evaluating GeoVax AIDS v...
Breaking Medicine Technology:Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 2Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 3Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS) 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 2Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 3Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 4Anadys Pharmaceuticals Resumes Clinical Investigation of TLR7 Mechanism in HCV 5Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 2Light Sciences Oncology Begins Clinical Trials of Litx Therapy in Patients with Enlarged Prostate 3GeoVax Reports Progress on Its AIDS Vaccine Technology 2GeoVax Reports Progress on Its AIDS Vaccine Technology 3GeoVax Reports Progress on Its AIDS Vaccine Technology 4GeoVax Reports Progress on Its AIDS Vaccine Technology 5Paradigm shift 3A Switch for programmed cell death promotes spread of glioblastoma 14025 1Paradigm shift 3A Switch for programmed cell death promotes spread of glioblastoma 14025 2Amphibians respond behaviorally to impact of clear cutting 2464 1Amphibians respond behaviorally to impact of clear cutting 2464 2Epigenetic changes discovered in major psychosis 2461 1Epigenetic changes discovered in major psychosis 2461 2Genesis Pharmaceuticals Changes Auditors 14020 1Genesis Pharmaceuticals Changes Auditors 14020 2
...FIELD, Mass.--(BUSINESS WIRE)--Jul 6, 2007 - Busin...race by pharmaceutical and,biotechnology companies...genesis treatment for cardiovascular disease. Whil...fi-Aventis, Boston,Scientific, Baxter, and Genzyme...ising new biological therapy for advanced,coronary...
...DGEWATER, N.J., July 05, 2007 /PRNewswire/ -- Resu...trolled, open-label, Phase,3 study showed that 77 ...ults taking PREZISTA(TM) (darunavir) 600 mg tablet...plus an optimized,background regimen (OBR) of anti...ad of <400 copies/mL at week 48, compared to 68,pe...
Other Medicine Technology:BusinessWeek Article Highlights Promising Breakthrough Treatment,for Advanced Coronary Artery Disease 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish.
Titanium. Designed to easily fold the hydroview lens. Will also fold many styles of soft intraocular lenses. Unique cross-action design facilitates folding of the lens.
30 degree angled tip with 45 mm tip opening. Stainless.
Insertion forcep used for the Hydroview lens. Manufactured in titanium.
Medicine Products: